Evidence map›Paper›PMID 39350956›Full record

ArticleRegenerative biomaterials2024

Engineered liver-derived decellularized extracellular matrix-based three-dimensional tumor constructs for enhanced drug screening efficiency.

Shengchang Luo, Qingqing Wang, Miaoting Li, Peiyao Xu, Yicheng Wang, Ying Wang, Ranjith Kumar Kankala, Shibin Wang, Aizheng Chen

Abstract read
In one paragraph

Article in Regenerative biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shengchang LuoInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Qingqing WangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Miaoting LiInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Peiyao XuInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Yicheng WangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Ying WangInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.ORCID https://orcid.org/0000-0001-6749-3848
Ranjith Kumar KankalaInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.ORCID https://orcid.org/0000-0003-4081-9179
Shibin WangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.
Aizheng ChenInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, PR China.ORCID https://orcid.org/0000-0002-5840-3406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The decellularized extracellular matrix (dECM) has emerged as an effective medium for replicating the

Indexed as

cancerdecellularized extracellular matrixmicrofluidicspreclinical drug screeningthree-dimensional tumor model

Identifiers

PMID39350956
PMCPMC11441757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.